đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to conduct long-term surveillance for efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-18
Trial ID
NCT02207816
The purpose of this observer-blind study is to gather key efficacy, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-27
Trial ID
NCT00866619
This study is being done to assess the possibility of the potential integra...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-30
Trial ID
NCT00436007
Treatments Being Tested
GSK Biologicals is developing a number of candidate malaria vaccines for th...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-07
Trial ID
NCT00307021
Treatments Being Tested
This phase IIb trial is being done to find out if the RTS,S/AS01 vaccine he...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-01-03
Trial ID
NCT00380393
Treatments Being Tested
This study has been designed to support the indication of the candidate vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-17
Trial ID
NCT01345240
The aim of the malaria vaccine program of the MVI/GSK partnership is to dev...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-13
Trial ID
NCT01231503
The purpose of this study is to show the consistency of different lots of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-16
Trial ID
NCT01323972
Treatments Being Tested
The RTS,S/AS02A vaccine (or GSK 257049 vaccine), GSK Biologicals' candidate...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04
Trial ID
NCT00323622
This study will investigate the safety and immunogenicity of 2 candidate ma...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-30
Trial ID
NCT00360230
Treatments Being Tested